Skip to main content
. Author manuscript; available in PMC: 2015 Jan 1.
Published in final edited form as: J Nucl Med. 2013 Dec 12;55(1):23–29. doi: 10.2967/jnumed.113.122630

FIGURE 6.

FIGURE 6

Tumor uptake of 18F-FDG and 64Cu-DOTA-trastuzumab (Day 1 and Day 2) vs. lesion site. Short horizontal lines indicate intra-site averages. * < 18F-FDG bone, P < 0.01; † > Day 2 bone, P < 0.02.